Fig. 1From: Efficacy and feasibility of ambulatory treatment-based monthly nedaplatin plus S-1 in definitive or salvage concurrent chemoradiotherapy for early, advanced, and relapsed esophageal cancerNedaplatin and S-1 combined with radiotherapy regimen treatment schemaBack to article page